Results 1 to 10 of about 1,335,851 (214)

Non-small-cell lung cancer [PDF]

Nature Reviews Disease Primers, 2015
Lung cancer is one of the most frequently diagnosed cancers and is the leading cause of cancer-related death worldwide. Non-small-cell lung cancer (NSCLC), a heterogeneous class of tumours, represents approximately 85% of all new lung cancer diagnoses. Tobacco smoking remains the main risk factor for developing this disease, but radon exposure and air ...
Gridelli, C, Rossi, A, Carbone, DP, Guarize, J, Karachaliou, N, Mok, T, Petrella, F, Spaggiari, L, Rosell, R   +8 more
semanticscholar   +8 more sources

Non-small cell lung cancer [PDF]

BMJ, 2012
This patient describes his experience of multidisciplinary care after his diagnosis of non-small cell lung cancer when he was 15 years ...
Andrew, Hill, Patricia, Fisher, Dan, Yeomanson   +2 more
semanticscholar   +6 more sources

Non–Small Cell Lung Cancer

Journal of the National Comprehensive Cancer Network, 2008
Lung cancer is the leading cause of cancer-related death in both men and women in the United States. An estimated 213,380 new cases (114,760 men and 98,620 women) of lung and bronchus cancer will be diagnosed in 2007, and 160,390 deaths (89,510 in men, 70,880 in women) are estimated to occur because of the disease.
David S, Ettinger, Wallace, Akerley, Gerold, Bepler, Andrew, Chang, Richard T, Cheney, Lucian R, Chirieac, Thomas A, D'Amico, Todd L, Demmy, Steven J, Feigenberg, Robert A, Figlin, Ramaswamy, Govindan, Frederic W, Grannis, Thierry, Jahan, Mohammad, Jahanzeb, Anne, Kessinger, Ritsuko, Komaki, Mark G, Kris, Corey J, Langer, Quynh-Thu, Le, Renato, Martins, Gregory A, Otterson, Jyoti D, Patel, Francisco, Robert, David J, Sugarbaker, Douglas E, Wood   +24 more
semanticscholar   +10 more sources

Non–Small Cell Lung Cancer [PDF]

Journal of the National Comprehensive Cancer Network, 2010
David S, Ettinger, Wallace, Akerley, Gerold, Bepler, Matthew G, Blum, Andrew, Chang, Richard T, Cheney, Lucian R, Chirieac, Thomas A, D'Amico, Todd L, Demmy, Apar Kishor P, Ganti, Ramaswamy, Govindan, Frederic W, Grannis, Thierry, Jahan, Mohammad, Jahanzeb, David H, Johnson, Anne, Kessinger, Ritsuko, Komaki, Feng-Ming, Kong, Mark G, Kris, Lee M, Krug, Quynh-Thu, Le, Inga T, Lennes, Renato, Martins, Janis, O'Malley, Raymond U, Osarogiagbon, Gregory A, Otterson, Jyoti D, Patel, Katherine M, Pisters, Karen, Reckamp, Gregory J, Riely, Eric, Rohren, George R, Simon, Scott J, Swanson, Douglas E, Wood, Stephen C, Yang   +34 more
openaire   +3 more sources

Non-small cell lung cancer [PDF]

Vnitřní lékařství, 2017
Non-small cell lung cancer (NSCLC) represents 80 % of diseases considering all patients with lung cancer. NSCLC comprises all histological types except for the small cell cancer. The treatment is chosen based on a clinical stage, morphological diagnosis and performance status of patients. In the low clinical stages a surgical solution is indicated.
Jana, Skřičková, Bohdan, Kadlec, Ondřej, Venclíček   +2 more
openaire   +2 more sources

Chinese Expert Consensus on Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations (2023 Edition)

Chinese Journal of Lung Cancer, 2023
With the development of precision diagnosis and treatment for non-small cell lung cancer (NSCLC), the epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins) mutations, as a rare subset of EGFR mutaions, have gradually attracted attention ...
Chinese Society of Clinical Oncology (CSCO) Non-small Cell Lung Cancer Committee
doaj   +1 more source

Non-small cell lung cancer

International Journal of Radiation Oncology*Biology*Physics, 1998
W. Sause
openaire   +2 more sources

RRx-001 in Refractory Small-Cell Lung Carcinoma: A Case Report of a Partial Response after a Third Reintroduction of Platinum Doublets. [PDF]

, 2016
RRx-001 is a pan-active, systemically nontoxic epigenetic inhibitor under investigation in advanced non-small cell lung cancer, small-cell lung cancer and high-grade neuroendocrine tumors in a Phase II clinical trial entitled TRIPLE THREAT (NCT02489903),
Brzezniak, Christina, Cabrales, Pedro, Caroen, Scott Z, Carter, Corey A, Degesys, Aiste, Kim, Michelle M, Lybeck, Harry, Oronsky, Arnold L, Oronsky, Bryan T, Oronsky, Neil, Reid, Tony, Roswarski, Joseph, Scicinski, Jan J   +12 more
core   +6 more sources

Expert Consensus on Prevention and Treatment of COVID-19 Infection in Patients with Lung Cancer

Chinese Journal of Lung Cancer, 2023
Corona virus disease 2019 (COVID-19) infection has become a major public health issue affecting human health. The main goal of epidemic prevention and control at the current stage in China is to “protect people’s health and prevent severe cases ...
Non-small Cell Lung Cancer Expert Committee of Chinese Society of Clinical Oncology, China Medical Education Association   +1 more
doaj   +1 more source

LncRNAs in Non-Small-Cell Lung Cancer [PDF]

Non-Coding RNA, 2020
Lung cancer is associated with a high mortality, with around 1.8 million deaths worldwide in 2018. Non-small-cell lung cancer (NSCLC) accounts for around 85% of cases and, despite improvement in the management of NSCLC, most patients are diagnosed at advanced stage and the five-year survival remains around 15%.
Lucy Ginn, Lei Shi, Manuela La Montagna, Michela Garofalo   +3 more
openaire   +4 more sources